Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach

oleh: Ash Bullement, Mark Edmondson-Jones, Nicholas Latimer

Format: Article
Diterbitkan: BMC 2024-07-01

Deskripsi

Subjek

Cost-effectiveness; Non-small cell lung cancer; Partitioned survival model; Hazard ratio; Proportional hazards; Network meta-analysis